Hemophilia Tea Leaves | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  167994 of 168914  at  9/30/2022 1:38:34 AM  by

akcje


 In response to msg 167990 by  rynotheknife
view thread

Re: Hemophilia Tea Leaves

 rynotheknife >  I think PFE's full year "pause" was a red herring 
  
Well, yes, they clearly had undisclosed reasons for the extended delay to the trial restart.
Perhaps waiting for more data on the already threated patients, to decide if to restart the trial or abort i.

Or they wanted  SGMO's valuation to drop while considering making or modifying a  deal with SGMO.   
Or...  

But in any case, restarting the trial is obviously good news. Apparently PFE doesn't share your thesis "  that ABR will likely be a trial-buster "  .   We shell see 
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...